Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Hepatocellular carcinoma is a rare disease in which cancerous cells are found in the tissues of your child’s liver. Although rare, it is the most common primary cancer of the liver.
This type of cancer is found in children from infants to birth to 19 year-old teenagers of age, but usually does not occur before the a child reaches age of 15.
The median age for diagnosis is 12 years old.
Hepatocellular carcinoma may occur in multiple places within your child’s liver.
Cancer cells can also spread (metastasize) to other areas of your child’s body.
The most common sites of metastasis are the lungs and the abdomen.
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center are conducting numerous research studies that will help clinicians better understand and treat hepatocellular carcinoma.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”